Welcome to the Urethral Stricture Support blog. These pages are intended to assist those with questions regarding the disease, expected outcomes, resources, and emotional and informational support. AT NO TIME WILL MEDICAL ADVICE OF ANY KIND BE RENDERED. With your permission, your commentary may be included within the topics discussed within this forum. Moderators Cesar and Tim have a combined 50 years (celebrating a half-century of difficult urination) of experience in living with, dealing with, and overcoming what is broadly considered a disease with a high rate of morbidity. We have experienced every common surgical and instrumental "fix"/"repair" offered including the implantation of the Urolume Endoprosthesis. Both moderators have experience with the Urolume Endoprosthesis. To the best of our knowledge, this is the first and only such support group anywhere. Please, do not be afraid or embarrassed to ask any question with regards to your diagnosis. We encourage you to discuss any and all information offered within this blog with your Urologist. A proactive and informed patient usually receives the best care.

With your help, and well-considered posts, the information gleaned from this site should help the countless scores of males aged 18 and over who are encountering the diagnosis of "Urethral Stricture".


DISCLAIMER: We do not provide medical advice. We disseminate information relevant to urethral stricture disease. While we encourage research (and participation in research), we endorse no medication or treatment protocols. PLEASE FEEL FREE TO CONTACT US WITH SPECIFIC QUESTIONS @ urethralstrictures[no spam] at yahoo dot com

Monday, December 5, 2011

Levaquin, off patent in 2010 - Levofloxacin now has full availablity in the U.S.

Late last year, Janssen's (actually Miles Pharmaceuticals) powerhouse fluroquinolone - LEVAQUIN, had its patent protection expire. What had been a $29.00 USD (per tablet, with a ten-tablet average per script) medication) as of July, 2011, has three generic rivals. Dr.Reddy's Labs (India, Mexico), Teva Pharmaceuticals (Israel, USA), and Greenstone, Ltd (Michigan, USA) each have approved versions of the medication available to the pharmaceutical market.

It has taken almost six months for availability and distribution to "hit every corner" of the U.S., Dr. Reddy's was the first available in my hometown in Pennsylvania. I've had no problems with the quality of any of Reddy Labs' offerings in the past, even though they've had issues .  Teva is a first-rate producer of pharmaceuticals, the "Cadillac" of generic drug makers (IMHO, Mylan is of equivalent stature). My pharmacist, whom I interviewed for this post, has had little experience with Greenstone, so I won't elaborate with regards to them.

Why has levofloxacin been so slow to saturate the market??  Primarily because of the costs involved with product liability insurance coverage borne by the manufacturer, distributor, and the pharmacy's liability carrier. Levofloxacin has a myriad of bad side effects, including effects on the heart, tendons, severe insomnia, and more. At least 50% of the retail cost of the generic med will reflect that liability cost, all of this adds up, and is the main reasoning behind the "slow to market" appearance of this life-saving, powerful anti-infective.

Per: Moderator Tim

Many thanks to MSP, R.Ph. for his help in compiling this info!!

No comments:

Post a Comment